← Research library

Thymogen as an adjunct in inflammatory gynecological conditions

Observational study · 1992

What was studied
46 patients with acute endomyometritis, exacerbated chronic salpingo-oophoritis or purulent tubo-ovarian disease received adjunctive Thymogen.
Main finding
A 46-patient report describes lymphocyte counts moving toward reference values and higher T-cell functional activity during combined care.

Reported findings and study design

Findings described in words

Historical adjunctive treatment report across several gynecological diagnoses.

Population or model 46 patients with acute endomyometritis, exacerbated chronic salpingo-oophoritis or purulent tubo-ovarian disease received adjunctive Thymogen.

Protocol information

The indexed abstract gives no dose, administration route, duration or companion drug schedules.

Protocol source ↗ · Original indexed abstract, cohort and reported immune outcomes.

Results · Original indexed abstract, cohort and reported immune outcomes.
MeasureResultComparison, timing and statistics
Lymphocyte indicesAuthors report normalization of lymphocyte counts and higher T-cell functional activity
Reported complicationsNone described in the abstractThe abstract gives no adverse-event ascertainment method.

Source for these results ↗ · Reviewed 2026-11-15

Study limitations and source details

Study limitations

  • The abstract gives no comparator denominator or numeric changes and does not establish Thymogen’s independent effect.

Source details

Original indexed abstract, cohort and reported immune outcomes.

Sources checked

Citation

Uncontrolled human reportEnglish abstract

Iu. V. Tsvelev, V. Kh. Khavinson, A. V. Diachuk, A. V. Gur’ev, S. V. Seryĭ. Thymogen as an adjunct in inflammatory gynecological conditions Akusherstvo i Ginekologiia (Moscow). 1992;(2):54–57.

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards